Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 1474

    1.

    Activation of IRS-2-mediated signal transduction by IGF-1, but not TGF-alpha or EGF, augments pancreatic beta-cell proliferation.

    Lingohr MK, Dickson LM, McCuaig JF, Hugl SR, Twardzik DR, Rhodes CJ.

    Diabetes. 2002 Apr;51(4):966-76.PMID: 11916914 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Differential activation of protein kinase B and p70(S6)K by glucose and insulin-like growth factor 1 in pancreatic beta-cells (INS-1).

    Dickson LM, Lingohr MK, McCuaig J, Hugl SR, Snow L, Kahn BB, Myers MG Jr, Rhodes CJ.

    J Biol Chem. 2001 Jun 15;276(24):21110-20. Epub 2001 Mar 27.PMID: 11274216 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    GTK tyrosine kinase-induced alteration of IRS-protein signalling in insulin producing cells.

    Annerén C, Welsh M.

    Mol Med. 2002 Nov;8(11):705-13.PMID: 12520087 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Free fatty acid-induced inhibition of glucose and insulin-like growth factor I-induced deoxyribonucleic acid synthesis in the pancreatic beta-cell line INS-1.

    Cousin SP, Hügl SR, Wrede CE, Kajio H, Myers MG Jr, Rhodes CJ.

    Endocrinology. 2001 Jan;142(1):229-40.PMID: 11145586 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Human glycated albumin affects glucose metabolism in L6 skeletal muscle cells by impairing insulin-induced insulin receptor substrate (IRS) signaling through a protein kinase C alpha-mediated mechanism.

    Miele C, Riboulet A, Maitan MA, Oriente F, Romano C, Formisano P, Giudicelli J, Beguinot F, Van Obberghen E.

    J Biol Chem. 2003 Nov 28;278(48):47376-87. Epub 2003 Sep 11.PMID: 12970360 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Fatty acid and phorbol ester-mediated interference of mitogenic signaling via novel protein kinase C isoforms in pancreatic beta-cells (INS-1).

    Wrede CE, Dickson LM, Lingohr MK, Briaud I, Rhodes CJ.

    J Mol Endocrinol. 2003 Jun;30(3):271-86.PMID: 12790799 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Differential insulin-like growth factor I receptor signaling and function in estrogen receptor (ER)-positive MCF-7 and ER-negative MDA-MB-231 breast cancer cells.

    Bartucci M, Morelli C, Mauro L, Andò S, Surmacz E.

    Cancer Res. 2001 Sep 15;61(18):6747-54.PMID: 11559546 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Insulin-like growth factor I-mediated protection from rapamycin-induced apoptosis is independent of Ras-Erk1-Erk2 and phosphatidylinositol 3'-kinase-Akt signaling pathways.

    Thimmaiah KN, Easton J, Huang S, Veverka KA, Germain GS, Harwood FC, Houghton PJ.

    Cancer Res. 2003 Jan 15;63(2):364-74.PMID: 12543789 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Transforming growth factor-alpha and epidermal growth factor activate mitogen-activated protein kinase and its substrates in intestinal epithelial cells.

    Oliver BL, Sha'afi RI, Hajjar JJ.

    Proc Soc Exp Biol Med. 1995 Nov;210(2):162-70.PMID: 7568287 [PubMed - indexed for MEDLINE]Related articles

    19.

    Insulin receptor substrate 2 and Shc play different roles in insulin-like growth factor I signaling.

    Kim B, Cheng HL, Margolis B, Feldman EL.

    J Biol Chem. 1998 Dec 18;273(51):34543-50.PMID: 9852124 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Signalling pathways of insulin-like growth factor-I that are augmented by cAMP in FRTL-5 cells.

    Ariga M, Nedachi T, Akahori M, Sakamoto H, Ito Y, Hakuno F, Takahashi S.

    Biochem J. 2000 Jun 1;348 Pt 2:409-16.PMID: 10816436 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Find related data